Hormone
somatostatin
so·mat·o·stat·in [ suh-mat-uh-stat-n, soh-muh-tuh- ]
Definitions related to somatostatin:
-
A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal.NLM Medical Subject HeadingsU.S. National Library of Medicine, 2021
-
Any of several cyclic tetradecapeptides elaborated primarily by the median eminence of the hypothalamus and by the delta cells of the pancreatic islets; they inhibit release of a variety of hormones, including growth hormone, thyrotropin, corticotropin, insulin, glucagon, gastrin, secretin and renin.CRISP ThesaurusNational Institutes of Health, 2006
-
Somatostatin is a polypeptide that is released in the gastrointestinal tract by delta cells and the hypothalamus. It functions as a key regulatory peptide that has many physiologic effects as an inhibitor for many other hormones, including gastrin, cholecystokinin, glucagon, growth hormone, insulin, secretin, pancreatic polypeptide,...WebMD, 2019
Return to OpenMD Medical Dictionary
> S
This content should not be used in place of medically-reviewed decision support reference material or professional medical advice. Some terms may have alternate or updated definitions not reflected in this set. The definitions on this page should not be considered complete or up to date.